Glaucoma Clinical Trial
Official title:
Short-term Outcomes of Iridoplasty for Persistent Angle Closure Despite Patent Iridotomies An Anterior Segment Optical Coherence Tomography Study
Purpose:
To evaluate short-term angle opening after argon peripheral iridoplasty using AS-OCT and to
report its complications at 1-week and 1-month follow up in patients that did not achieve a
satisfactory clinical angle opening despite patent laser peripheral iridotomy.
Design:
Prospective, Interventional case series
Subjects:
Patients with an occludable angle in more than two quadrants in dark room indentation
gonioscopy and patent iridotomies of at least 2 weeks, with assessment of persistent angle
closure aetiology by ultrabiomicroscopy and A-scan ultrasound are included.
Patients will undergo complete examination and AS-OCT before ALPI, one week and one month
after it. We analyzed the images in a masked manner and took the angle measurements (AOD500,
AOD 750, TISA500, TISA750, ARA500, ARA 750, Lens vault) at 0° and 180° as the main outcome
measure to determine effectiveness.
Background Argon laser peripheral iridoplasty (ALPI) (Figure 1) is an iris-remodeling
procedure that intends to widen the iridocorneal angle through redistribution of peripheral
iris tension forces close to the trabeculum.
ALPI is effective in patients with plateau iris syndrome and acute angle closure glaucoma
but there is less published about its effectiveness in secondary angle closure. Therefore,
we are going to evaluate this procedure in those patients that did not achieve a
satisfactory clinical angle opening despite patent laser peripheral iridotomy, as long as
there was no contraindication for a new laser procedure and provided that cataract surgery
is not viable, as in clear lens or patients not willing to undergo surgery.
To evaluate its effectiveness, we will use a non-invasive non-contact method through
anterior segment optical coherence tomography (AS-OCT), which transmits and receives light
in an ultrasound-like manner to obtain anterior segment imaging that helps to evaluate the
angle more objectively.
Purpose To evaluate short-term angle opening after argon peripheral iridoplasty using AS-OCT
and to report its complications at 1-week and 1-month follow up in patients with persistent
angle closure despite patent iridotomies.
Study Design Prospective, interventional case series Patients with an occludable angle in
more than two quadrants in dark room dynamic gonioscopy and patent iridotomies of at least 2
weeks were included. A supplemental diagnosis regarding the etiology of persistent angle
closure by ultrabiomicroscopy and A-scan ultrasound will be obtained. Patients who presented
with these criteria to the angle closure clinic at the glaucoma service of our institute
(Instituto de Oftalmologia Fundacion Conde de Valenciana IAP, Mexico City) between July and
November 2012 were included.
Patients with synechiae of more than one quadrant, advanced glaucomatous damage, prompt
cataract surgery plans and those who did not wish to participate were excluded.
After obtaining informed consent, patients underwent biomicroscopy, gonioscopy, visual
acuity, intraocular pressure and AS-OCT before ALPI, one week and one month after it. The
AS-OCT Visante (Carl Zeiss Meditec, Dublin) took an image of the vertical and horizontal
meridians at the same room illumination of 14 lux measured with a luxometer mobile
application (Apple Inc., Application Manufactory available at the AppStore by June 2012).
Images were analyzed in a masked manner marking scleral spurs and angle recess at 0° and
180° of the horizontal image.
ALPI was applied with a VISULAS diode laser of 532 nm (Carl Zeiss Meditec, Dublin, CA) by
the same ophthalmologist (JML). Twenty to 40 spots of 400 mW power with 500 microns of size
and duration of 500 ms were applied. Power was modified arbitrarily until an effective iris
contraction was obtained. It was considered an effective contraction as that which causes a
concentric movement around the laser spot, with minimal iris pigmentation and immediate
angle opening observed through the lens mirrors using a Goldmann lens. Power was lowered if
there was any bursting sound perceived, pigment dispersion, air bubbles or considerable
pain. Pilocarpine was not applied before the procedure in all cases because some eyes had
angle closure secondary to ciliary block and we considered it could worsen the closure in
many cases.
Topical prednisolone acetate was applied every 4 hours for 1 week and brimonidine tartrate
every 12 hours for 1 week .
;
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06000865 -
Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE
|
N/A | |
Recruiting |
NCT06278597 -
Automatic Evaluation of the Anterior Chamber Angle Width by a New Non-contact Optical Device
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03274024 -
The Asia Primary Tube Versus Trab (TVT) Study
|
N/A | |
Completed |
NCT04552964 -
Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma
|
N/A | |
Recruiting |
NCT01957267 -
Functional and Structural Imaging for Glaucoma
|
||
Active, not recruiting |
NCT04624698 -
iStent Inject New Enrollment Post-Approval Study
|
N/A | |
Completed |
NCT04020705 -
The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma
|
N/A | |
Completed |
NCT03150160 -
Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma
|
Phase 4 | |
Not yet recruiting |
NCT05581498 -
Glaucoma Exercise as Medicine Study (GEMS).
|
N/A | |
Recruiting |
NCT02921568 -
Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes
|
N/A | |
Active, not recruiting |
NCT02901730 -
Clinical Study of LPI With Different Laser Wavelengths
|
N/A | |
Completed |
NCT02955849 -
A Trial of China Laser and Surgery Study Glaucoma in Rural China
|
Early Phase 1 | |
Recruiting |
NCT02471105 -
Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml
|
Phase 4 | |
Recruiting |
NCT02554214 -
Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device
|
N/A | |
Active, not recruiting |
NCT02390284 -
Stop Retinal Ganglion Cell Dysfunction Study
|
Phase 3 | |
Completed |
NCT02628223 -
180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma
|
N/A | |
Completed |
NCT02390245 -
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
|
N/A | |
Completed |
NCT02653963 -
Triamcinolone for Ahmed Glaucoma Valve
|
N/A | |
Completed |
NCT02246764 -
Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
|
Phase 3 |